What is the significance, if any, of the increased incidence of stent thrombosis with dual therapy of dabigatran 110 mg twice daily and clopidogrel in the RE-DUAL PCI trial?
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.